Streetbeat News

Analyst Ratings

BMRN

Scotiabank analyst George Farmer has initiated coverage on Biomarin Pharmaceutical (NASDAQ:BMRN) with a Sector Perform rating and a price target of $95.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 1:40 pm

MRTX

Scotiabank analyst George Farmer has initiated coverage on Mirati Therapeutics (NASDAQ:MRTX) with a Sector Underperform rating and a price target of $20.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 1:39 pm

RIVN

Tigress Financial analyst Ivan Feinseth has reiterated a 'Buy' rating on Rivian Automotive (NASDAQ:RIVN) and announced a price target of $36.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:39 pm

TMO

Baird analyst Catherine Schulte has maintained an Outperform rating on Thermo Fisher Scientific (NYSE:TMO) but lowered the price target from $664 to $625.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 27, 2023 | 1:38 pm

SAGE

Scotiabank analyst George Farmer has initiated coverage on Sage Therapeutics (NASDAQ:SAGE) with a Sector Outperform rating and a price target of $61.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 1:37 pm

ACGL

JP Morgan analyst Jimmy Bhullar maintains a Neutral rating on Arch Capital Group (NASDAQ:ACGL) and raises the price target from $75 to $82.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:37 pm

AURA

Scotiabank analyst George Farmer has initiated coverage on Aura Biosciences (NASDAQ:AURA) with a Sector Outperform rating and a price target of $23.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 1:36 pm

ENVX

EF Hutton analyst Tim Moore has reiterated a 'Buy' rating on Enovix (NASDAQ:ENVX) and raised the price target from $21 to $22.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:34 pm

MCD

TD Cowen analyst Andrew Charles has reiterated an Outperform rating on McDonald's (NYSE:MCD) and maintained a price target of $326.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:34 pm

META

UBS analyst Lloyd Walmsley maintains a Buy rating on Meta Platforms (NASDAQ:META) and raises the price target from $335 to $400.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 27, 2023 | 1:34 pm